Voydaya – pro

VOYDEYA (danicopan) is
a prescription medicine used as an add-on therapy to ravulizumab (Ultomiris) or eculizumab (Soliris) to treat adults with paroxysmal nocturnal hemoglobinuria (PNH) who experience ongoing extravascular hemolysis (EVH)

Voydaya Precribing Information 2025

Lee JW, et al. Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial. The Lancet Haematology. 2023;10(12):E955-E965.

Categories

Blog Archives